Operose Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.82K Hold
2025
Q1
$6.87K Hold
2024
Q4
$7.95K Hold
2024
Q3
$9.49K Hold
2024
Q2
$10.9K Hold
2024
Q1
$13.8K Hold
2023
Q4
$12.6K Hold
2023
Q3
$9.17K Buy
2023
Q2
$11.2K Hold
2023
Q1
$9.05K Buy